- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07857811
Evaluation of Aortic-Radial Blood Pressure Gradient in Pediatric Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass (GARP)
Invasive blood pressure monitoring is essential during heart surgery. Usually, doctors measure blood pressure using a small tube (a catheter) placed in an artery, typically in the wrist or arm. During surgeries that require a heart-lung machine (cardiopulmonary bypass), doctors can also measure blood pressure directly near the heart in the main artery (the aorta). This is done using a tube already in place for the machine, so no extra procedure is needed.
In adult patients, doctors have noticed that blood pressure readings taken at the arm can sometimes be significantly different from readings taken near the heart right after coming off the heart-lung machine. This difference could lead to unnecessary or incorrect treatments if medical teams rely only on arm readings. However, it is still unknown whether this same difference occurs in children.
The goal of this study is to measure and compare blood pressure from both the arm and near the heart in children aged 3 years and younger as they come off the heart-lung machine during heart surgery. This research will help medical teams make safer, more accurate treatment decisions for children undergoing heart surgery.
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Accurate arterial blood pressure monitoring is essential during and after cardiopulmonary bypass (CPB) in pediatric cardiac surgery. However, a significant gradient between radial and central aortic pressure has been reported, which could lead to erroneous clinical decisions if radial pressure is overestimated. Although this phenomenon has been studied in adults, its incidence, associated factors, and clinical implications in pediatric patients under 3 years of age remain to be clearly established.
This study proposes a prospective observational cohort design including 100 patients under 3 years of age undergoing cardiac surgery with CPB and invasive radial arterial monitoring. The study will evaluate the incidence of a significant radial-to-aortic gradient (defined as a >20% difference in SBP or >10% in MAP sustained for more than 5 minutes), alongside biometric and surgical risk factors, and its relationship with clinical outcomes such as vasoactive drug requirements, blood transfusions, and duration of mechanical ventilation.
Statistical analysis will be performed using descriptive statistics, bivariate testing, and multivariate LASSO logistic regression. This study is expected to identify a pediatric risk profile for developing a significant pressure gradient, thereby optimizing decision-making regarding arterial monitoring sites and post-CPB hemodynamic management. Ultimately, this research aims to address a clinically relevant knowledge gap and enhance perioperative safety in this highly vulnerable population.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Santiago Arze, MD
- Número de teléfono: +56955049217
- Correo electrónico: sarze@uc.cl
Copia de seguridad de contactos de estudio
- Nombre: Valeria Pizarro, MD
- Número de teléfono: +56962283715
- Correo electrónico: vale.pizarro@uc.cl
Ubicaciones de estudio
-
-
Santiago Metropolitan
-
Santiago, Santiago Metropolitan, Chile, 8320000
- Reclutamiento
- Pontificia Universidad Católica de Chile
-
Santiago, Santiago Metropolitan, Chile, 8320000
- Reclutamiento
- Red de Salud UC Christus
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Pediatric patients from 0-3 years of age
Descripción
Inclusion Criteria:
- Patients from 0 to 3 years old
- Cardiac surgery with cardiopulmonary bypass (CPB)
- Invasive blood pressure monitoring via radial artery
Exclusion Criteria:
- Patients in whom radial cannulation is not achieved
- Significant vascular malformations that may interfere with or contraindicate invasive radial blood pressure measurement
- Emergency surgeries
- Reinterventions during the same hospital stay
- Technical complications preventing reliable direct aortic pressure measurement
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Study group
Patients under 3 years of age undergoing cardiac surgery with cardiopulmonary bypass (CPB) at the UC-Christus Clinical Hospital. |
Placement of a pressure transducer at the accessory port of the cardiopulmonary bypass (CPB) arterial cannula during the final phase of CPB and the immediate post-CPB period. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
To evaluate the occurrence of a significant radial-to-aortic (R-Ao) pressure gradient during the immediate post-cardiopulmonary bypass (CPB) period
Periodo de tiempo: within 15 minutes from the weaning of the CBP
|
A significant radial-to-aortic (R-Ao) pressure gradient is defined as a >20% difference in SBP or >10% difference in MAP sustained for >5 minutes) during the immediate post-cardiopulmonary bypass (CPB) period |
within 15 minutes from the weaning of the CBP
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
To determine the incidence of the R-Ao gradient in pediatric patients undergoing cardiac surgery with CPB and compare it with reported rates in the adult literature.
Periodo de tiempo: Within the first 15 minutes after CPB weaning.
|
R-Ao Gradient Incidence: percentage of positive finding to the total of recruited patients in the study. Reported Rates in adult population: As per an exhaustive review of previous literature. |
Within the first 15 minutes after CPB weaning.
|
|
To identify risk factors associated with a higher R-Ao gradient, based on patient biometric parameters and surgical variables
Periodo de tiempo: From enrollment to 48 hours after surgery
|
Patient variables: age, body surface area [BSA], radial artery diameter Surgery variables: CPB duration and use of hypothermia Outcome Measure: Odds Ratio |
From enrollment to 48 hours after surgery
|
|
To compare vasoactive drug requirements/dosages between patients with and without a significant arterial gradient
Periodo de tiempo: within 30 minutes from the weaning of the CBP, up to 48 hours after surgery.
|
The comparison will be made using VIS score, as: VIS = dopamine + dobutamine + (100 × epinephrine) + (100 × norepinephrine) + (10 × milrinone) + (10,000 × vasopressin) It will be measured at three time periods: 30 mins post CPB, Postoperative Day 1 and Postoperative Day 2 |
within 30 minutes from the weaning of the CBP, up to 48 hours after surgery.
|
|
To compare the duration of invasive mechanical ventilation between patients with and without a significant arterial gradient.
Periodo de tiempo: within the first 48 hours following weaning of the CBP
|
within the first 48 hours following weaning of the CBP
|
|
|
To compare the incidence of post-CPB blood transfusion between patients with and without a significant arterial gradient.
Periodo de tiempo: within the first 48 hours following weaning of the CBP
|
within the first 48 hours following weaning of the CBP
|
|
|
To compare the incidence of renal dysfunction between patients with and without a significant arterial gradient.
Periodo de tiempo: within 48 hours following weaning of the CBP
|
within 48 hours following weaning of the CBP
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Santiago Arze, MD, División de Anestesiología, Pontificia Universidad Católica de Chile
Publicaciones y enlaces útiles
Publicaciones Generales
- Stern DH, Gerson JI, Allen FB, Parker FB. Can we trust the direct radial artery pressure immediately following cardiopulmonary bypass? Anesthesiology. 1985 May;62(5):557-61. doi: 10.1097/00000542-198505000-00002.
- Jacquet-Lagreze M, Costescu A, Denault A. Can we trust radial artery pressure monitoring for cardiac surgery? Can J Anaesth. 2022 Nov;69(11):1319-1326. doi: 10.1007/s12630-022-02321-1. Epub 2022 Oct 5. No abstract available.
- Bouchard-Dechene V, Kontar L, Couture P, Perusse P, Levesque S, Lamarche Y, Denault AY; Montreal Heart Institute Research Team. Radial-to-femoral pressure gradient quantification in cardiac surgery. JTCVS Open. 2021 Aug 5;8:446-460. doi: 10.1016/j.xjon.2021.07.031. eCollection 2021 Dec.
- Dhanyee AS, Parida S, Thangaswamy CR, Jha AK, Rajappa M, Munuswamy H, Mishra SK. Relationship between difference of preoperative and cardiopulmonary bypass mean arterial pressure, and acute kidney injury in cardiac surgical patients undergoing valve surgery. Perfusion. 2025 Jan;40(1):164-173. doi: 10.1177/02676591231226161. Epub 2024 Jan 5.
- Oh AR, Hong KY, Park J, Her S, Lee JH. Risk factors for femoral-to-radial artery pressure gradient after weaning from cardiopulmonary bypass: a historical cohort study. Can J Anaesth. 2022 Nov;69(11):1330-1339. doi: 10.1007/s12630-022-02320-2. Epub 2022 Oct 6.
- Pauca AL, Hudspeth AS, Wallenhaupt SL, Tucker WY, Kon ND, Mills SA, Cordell AR. Radial artery-to-aorta pressure difference after discontinuation of cardiopulmonary bypass. Anesthesiology. 1989 Jun;70(6):935-41. doi: 10.1097/00000542-198906000-00009.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 250425011
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .